Jan 5, 2016Millendo Therapeutics snags $62 Million Series BAnn Arbor, Michigan-based Millendo Therapeutics (formerly known as Atterocor Inc), a biopharmaceutical company focused on treating orphan...
Dec 23, 2015eFFECTOR Therapeutics Raises $40 Million Series B FinancingSAN DIEGO, December 22, 2015 – eFFECTOR Therapeutics, a biopharmaceutical company developing translation regulators for the treatment of...